Aclarion Inc
ACON
View Detailed Chart
5.880USD
-0.110-1.84%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
3.42MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.84%
5 Days
-0.34%
1 Month
-4.62%
6 Months
-13.53%
Year to Date
-99.55%
1 Year
-99.49%
View Detailed Chart
TradingKey Stock Score of Aclarion Inc
Currency: USD Updated: 2025-12-24Key Insights
Aclarion Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 210/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 23.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Aclarion Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
23.000
Target Price
+291.16%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Aclarion Inc Highlights
StrengthsRisks
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Growing
The company is in a growing phase, with the latest annual income totaling USD 45.72K.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 6.78K shares of this stock.
Aclarion Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Aclarion Inc Info
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Ticker SymbolACON
CompanyAclarion Inc
CEONess (Brent)
Websitehttps://aclarion.com/
FAQs
What is the current price of Aclarion Inc (ACON)?
The current price of Aclarion Inc (ACON) is 5.880.
What is the symbol of Aclarion Inc?
The ticker symbol of Aclarion Inc is ACON.
What is the 52-week high of Aclarion Inc?
The 52-week high of Aclarion Inc is 3499.510.
What is the 52-week low of Aclarion Inc?
The 52-week low of Aclarion Inc is 5.550.
What is the market capitalization of Aclarion Inc?
The market capitalization of Aclarion Inc is 3.42M.
What is the net income of Aclarion Inc?
The net income of Aclarion Inc is -7.05M.
Is Aclarion Inc (ACON) currently rated as Buy, Hold, or Sell?
According to analysts, Aclarion Inc (ACON) has an overall rating of Buy, with a price target of 23.000.
What is the Earnings Per Share (EPS TTM) of Aclarion Inc (ACON)?
The Earnings Per Share (EPS TTM) of Aclarion Inc (ACON) is -1598.314.
Related Instruments
+0.41%
+0.94%
+0.51%
+0.34%
-0.17%
+1.42%
+0.75%
+1.80%
+0.38%
+0.66%
+0.08%
+0.82%
+0.81%
+0.08%
+0.23%
-0.05%
-0.19%
0.00%
+1.54%
+0.50%
